You are here

Home

Clinical Trials: Wounds and Injuries

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, September 4, 2020 - 12:00
Mesenchymal Stem Cell-derived Pleiotropic Factor in the Treatment of Poor Healing of Postoperative Incision
Condition:   MSCs Derived Pleiotropic Factors in Treating Poorly Healed Wounds
Intervention:   Biological: The pleiotropic factor derived from mesenchymal stem cells
Sponsors:   Chinese PLA General Hospital;   Gansu Provincial Maternity and Child-Care Hospital
Not yet recruiting
Posted: Wednesday, September 2, 2020 - 12:00
Effects of MSCs Derived Pleiotropic Factors on Wound Healing in Endonasal Surgeries
Condition:   MSCs Derived Pleiotropic Factors on Wound Healing in Endonasal Surgeries
Interventions:   Biological: MSCs Derived Pleiotropic Factors;   Other: physiological saline
Sponsor:   Chinese PLA General Hospital
Not yet recruiting
Posted: Monday, August 31, 2020 - 12:00
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Conditions:   Trauma;   Adult Stem Cells
Interventions:   Biological: MultiStem;   Biological: Placebo
Sponsors:   Athersys, Inc;   Memorial Hermann Hospital;   United States Department of Defense
Not yet recruiting
Posted: Thursday, August 27, 2020 - 12:00
Autologous Bone Marrow-derived Mononuclear Cells for Acute Spinal Cord Injury
Condition:   Spinal Cord Injury
Interventions:   Biological: Autologous bone marrow-derived mononuclear cells;   Drug: Placebo
Sponsor:   Shanghai Changzheng Hospital
Not yet recruiting
Posted: Thursday, August 20, 2020 - 12:00
Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients
Conditions:   Spinal Cord Injuries;   Paralysis
Interventions:   Other: Best Medical Management: Occupational and Physical Therapy;   Biological: Autologous, Adipose Derived Mesenchymal Stem Cells
Sponsor:   Allan Dietz
Recruiting
Posted: Tuesday, August 4, 2020 - 12:00
Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers
Condition:   Diabetic Foot Ulcer
Intervention:   Biological: ALLO-ASC-SHEET
Sponsor:   Anterogen Co., Ltd.
Not yet recruiting
Posted: Wednesday, July 22, 2020 - 12:00
RAPA-501-Allo Off-the-Shelf Therapy of COVID-19
Condition:   Severe COVID-19 Disease
Interventions:   Biological: RAPA-501-Allo off-the-shelf Therapy of COVID-19;   Other: Placebo
Sponsors:   Rapa Therapeutics LLC;   Hackensack Meridian Health
Not yet recruiting
Posted: Wednesday, June 24, 2020 - 12:00
A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy
Conditions:   COVID-19;   Acute Kidney Injury
Interventions:   Biological: SBI-101;   Device: Sham
Sponsor:   Sentien Biotechnologies, Inc.
Not yet recruiting
Posted: Thursday, April 2, 2020 - 12:00
Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS
Conditions:   COVID-19;   Acute Respiratory Distress Syndrome;   Virus; Pneumonia;   Acute Lung Injury
Intervention:   Biological: CAStem
Sponsors:   Chinese Academy of Sciences;   Beijing YouAn Hospital
Recruiting
Posted: Friday, February 28, 2020 - 12:00
Treatment of Spinal Cord Injuries With (AutoBM-MSCs)vs (WJ-MSCs).
Condition:   Spinal Cord Injuries
Interventions:   Biological: Collection and expansion of BM-MSC;   Diagnostic Test: VI-SCI evaluation and patients' follow up
Sponsor:   University of Jordan
Recruiting

Pages